Advertisement

Banner Biovision 2014 Lyon France April 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6322 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 62 63 64  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Qiagen–Trinean: UV/VIS spectrophotometer, 201401– OEM manufacture + supply ww of QIAxpert system by Trinean 2014-01-18
Boehringer–Argen-X: SIMPLE antibody discovery platform, 201401– collab €na pilot research agreement 2014-01-13
Hopp Group–GATC Biotech: DNA sequencing, 201401– supply protocols + support + training + LIMS to Molecular Health Inc 2014-01-10
Probi–Symrise: investment, 201401– mandatory offering SEK40.1/share for all remaining shares of Probi AB after increase of Symrise holdings to 30.03% 2014-01-10
Aravis–College Group: public relations, 201401 service existent by College Hill Life Sciences 2014-01-09
Isarna Therapeutics–Santaris Pharma: LNA technology, 201401– license for use to discovery + develop + market TGF beta targeting immunotherapies 2014-01-08
Boehringer–Crystal Bioscience: therapeutic antibodies, 201401– collab discovery + developm for multiple targets 2014-01-07
Isarna Therapeutics–MIG Fonds: investment, 201401 financing round €13m from AT NewTec + MIG-managed funds 2014-01-07
Isarna Therapeutics–SEVERAL: investment, 201401 financing round €13m from AT NewTec + MIG-managed funds 2014-01-07
Isarna Therapeutics–Strüngmann Group: investment, 201401 financing round €13m from AT NewTec + MIG-managed funds 2014-01-07
AstraZeneca–Probiodrug: CDK9 inhibitors, 201401 acquistion €na of CDK9 inhibitor program by AstraZeneca 2014-01-03
Dinkelberg Analytics–Altmann Analytik: investment, 201401 acquisition 2014-01-01
Helmholtz–NN: mass spectrometer, 2014 supply PLANNED installation of SIMS at UFZ in Leipzig 2014-01-01
Laboratorios LETI–Curetis: Unyvero system, 201401– distribution excl in Spain + Portugal by Laboratorios LETI 2014-01-01
Optronik–Carl Zeiss: investment, 201312 acquisition 100% of former excl Turkish distribution partner by Carl Zeiss Meditec 2013-12-31
Boehringer–Circuit Therapeutics: drug target discovery, 201312– collab research €na 3y in field of psychiatric disorders 2013-12-18
Merck (DE)–CNIO: ATR kinase inhibitor, 201312– license excl rights to develop + commercialise ATR kinase inhibitors to Merck Serono 2013-12-18
Structural Genomics Consortium–Bayer: epigenetics, 201312– collab Bayer HealthCare joins SGC as new member 2013-12-18
Emergent BioSolutions–Minapharm: AGE1.CR cell line, 201312– license expansion €na broad non-excl commercial multi-product from ProBioGen 2013-12-17
Automation Partnership–Sartorius: investment, 201310–201312 acquisition €33m in cash of TAP Biosystems Group plc by Sartorius Stedim Biotech GmbH 2013-12-16
Strüngmann Group–Formycon: biosimilar, 201312– license ww excl to first biosimilar in Formycon’s pipeline to Santo Holding GmbH 2013-12-12
Bayer–Druggability Technologies: drug delivery technology, 201312– collab multi-year to deploy Super-API platform to Bayer HealthCare molecules 2013-12-05
FN Semillas–Bayer: investment, 201312 acquisition €na by Bayer CropScience 2013-12-05
Sonic Healthcare–Ariosa Diagnostics: Harmony Prenatal Test, 201312– supply Sonic Healthcare will offer test via Bioscientia in Germany 2013-12-05
Euroimmun–Mecklenburg-Vorpommern (govt): grant, 201312– grant €3.15m to support total Euroimmun €14m investment to expand Dassow facility 2013-12-04
Pfizer–Protagen: biomarker discovery services, 201312– collab use SeroTag process to identify markers for autoimmune drug developm 2013-12-03
Paion–Capital Ventures International: investment, 201312–201402 private placement €6.17 acquisition 2.55m new shares in 2 tranches by CVI 2013-12-01
TocopheRx–Merck (DE): investment, 201312 seed financing $3.2m from MS Ventures for spin-off from Merck Serono 2013-12-01
Algeta–Bayer: investment, 201311– acquisition proposal by Bayer NOK362/share valuing Algeta equity at €2.1b 2013-11-26
R-Pharm–Paion: remimazolam, 201310– license excl €1m upfront + €3m milestones + royalties for developm + manuf + marketing in Russia + CIS 2013-11-26
R-Pharm–Paion: remimazolam, 201311– license €1m upfront + €3m milestones + royalties for developm + marketing in Turkey to TR-Pharm 2013-11-26
Boehringer–Galapagos: drug discovery, 201311– supply integrated drug discovery services by BioFocus to undisclosed Boehringer target 2013-11-20
Definiens–Affect: public relations, 201311 service existent by Affect Inc 2013-11-20
Global Bioenergies–Germany (govt): grant, 201311– BMBF grant €5.7m for Global Bioenergies GmbH within BioEconomy programme 2013-11-20
Merck (DE)–Biopharm: therapeutic protein, 201311– collab €na r+d biopharmaceutical for osteoarthritis with Merck Serono 2013-11-20
Metamark Genetics–Definiens: image analysis s/w, 201311– collab + supply multi-year agreem to use Cognition Network Technology with ProMark test 2013-11-20
CI3 Cluster–AbbVie: personalised immunotherapy, 201311 collab existent AbbVie Deutschland GmbH & Co KG is cluster partner 2013-11-19
CI3 Cluster–Bayer: personalised immunotherapy, 201311 collab existent Bayer Vital GmbH is cluster partner 2013-11-19
CI3 Cluster–Biopharm: personalised immunotherapy, 201311 collab existent PW Technologies GmbH is cluster partner 2013-11-19
CI3 Cluster–Dr Falk Pharma: personalised immunotherapy, 201311 collab existent Dr Falk Pharma GmbH is cluster partner 2013-11-19
CI3 Cluster–GenXPro: personalised immunotherapy, 201311 collab existent GenXPro GmbH is cluster partner 2013-11-19
CI3 Cluster–Infraserv Höchst: personalised immunotherapy, 201311 collab existent Infraserv GmbH & Co Hoechst KG is cluster partner 2013-11-19
CI3 Cluster–itechpartners: personalised immunotherapy, 201311 collab existent itechpartners – Dr Rainer Wessel is cluster partner 2013-11-19
CI3 Cluster–Medatixx: personalised immunotherapy, 201311 collab existent Medatixx GmbH & Co KG is cluster partner 2013-11-19
CI3 Cluster–Medesso: personalised immunotherapy, 201311 collab existent Medesso GmbH is cluster partner 2013-11-19
CI3 Cluster–Molekularpathologie Trier: personalised immunotherapy, 201311 collab existent ProteoPath GbR is cluster partner 2013-11-19
CI3 Cluster–thinXXS Microtechnology: personalised immunotherapy, 201311 collab existent thinXXS Microtechnology AG is cluster partner 2013-11-19
Scopis–High-Tech Gründerfonds: investment, 201311 financing round Series A incl returning investor HTGF 2013-11-19
Scopis–SEVERAL: investment, 201311 financing round Series A from HTGF + VC Fonds Technologie Berlin + Falk Strascheg + Fraunhofer 2013-11-19
Strüngmann Group–SEVERAL: investment, 201311 Ganymed financing round Series E €45m from existing investors ATS + MIG Fond + FCPB Gany GmbH 2013-11-18
Merck (DE)–BeiGene: cancer drug, 201311– license ww + collab co-developm + commercialisation of PARP inhibitor BeiGene-290 by Merck Serono 2013-11-13
R-Biopharm–Candor Bioscience: immunoassays, 201311– strategic alliance in the area of companion diagnostics 2013-11-13
Roche–Immatics: cancer immunotherapy, 201311– strategic r+d collab €17m upfront + research funding + >€1b milestones to develop cancer vaccines 2013-11-13
Coral BioNet–Wacker: investment, 201311– acquisition 100% of Scil Proteins Production GmbH by Wacker Biotech GmbH from BioNet Ventures GmbH 2013-11-12
MeVis–PERSON: investment, 201311 shareholding of voting rights of Carl JG Evertsz has fallen to 14.995% 2013-11-11
JnJ–Evotec: drug discovery services, 201311– collab drug target discovery for Alzheimer drugs with JnJ Innovation Centre California 2013-11-08
Hookipa Biotech–Boehringer: investment, 201311 financing round Series B totalling €20m incl new + co-investor BIVF 2013-11-04
Merck (DE)–Kadimastem: drug discovery services, 201311– collab MOU drug screening + discovery for neurodegenerative disesases Merck Serono 2013-11-04
Strüngmann Group–4SC: drug discovery services, 201311– collab discovery + optimis small molecule anti-infectives by 4SC Discovery+Crelux for AiCuris 2013-11-04
Thermo Fisher–Univ Utrecht: mass spectrometry, 201311– collab developm applications + appointm of A Makarov as Professor 2013-11-04
AlBioTex project–Germany (govt): grant, 201311– BMBF co-funding for research project on microbial production of biopolymers for medtech + textiles 2013-11-01
CRM Clinical Trials–Venn Life Sciences: investment, 201310 acquisition €0.6m in shares ANNOUNCED 2013-10-31
IROA Technologies–Bruker Corp: mass spectrometer, 201310 supply existent IROA uses Bruker MS for metabolomics research 2013-10-31
Merck (DE)–Max Planck: drug discovery services, 201310– collab 5y strategic partnership of Merck Serono with Lead Discovery Center GmbH 2013-10-31
Ako med–Curetis: Unyvero system, 201310 distribution existent Ako med doo is distributor in countries of former Yugoslavia for system + cartridges 2013-10-30
BioLine (RU)–Curetis: Unyvero system, 201310 distribution existent BioLine LLC is Russian distribution partner for system + cartridges 2013-10-30
BioChain–Epigenomics: molecular diagnostics, 201310– broad strategic collaboration expanding prior license agreement for China 2013-10-28
Cell Signaling Technology–RainDance: RainDrop Digital PCR System, 201310– distribution by BIOKÉ in Germany + Benelux 2013-10-28
Epigenomics–BioChain: investment, 201310 acquisition €0.94m ($1.3m) of 217.9k new shares as part of strategic collaboration 2013-10-28
Formycon–SEVERAL: investment, 201310–201312 capital increase €9.4m 1.257m new common shares €7.5/share to existent shareholders 2013-10-28
Genetrix (ES)–SEVERAL: investment, 201310 rights offering + private placement of Sygnis AG €2.7m with 1.02m new shares €2.65/share 2013-10-28
Hana Pharmaceuticals–Paion: remimazolam, 201310– license excl €1m upfront + €2m milestones + 10% royalties for dev + manuf + commerc in Korea 2013-10-28
Biotest–SEVERAL: credit, 201310– placing of €210m notes in different tranches to more than 70 investors 2013-10-24
Merck (DE)–Polyplus-transfection: transfection reagents, 201310– license + supply agreem €na for PEI-based transfection reagents incl PEIpro 2013-10-24
Celesio–McKesson: investment, 201310– acquisition €6.1b with acqu of 50.01% shares from Haniel + cash tender offer for all remaining shares €23/share 2013-10-23
Boehringer–Beactica: drug discovery services, 201310– collab expansion €na fragment-based drug discovery services for oncology-relevant kinases 2013-10-22
Heraeus–Curetis: molecular diagnostics, 201310 collab existent co-developm + co-marketing of Unyvero i60 ITI application 2013-10-22
AstraZeneca–Evotec: kidney disease drugs, 201310– license + collab agreem €na giving AZ access to selected series of molecules to treat CKD 2013-10-21
Clovis Oncology–Qiagen: molecular companion diagnostics, 201310– collab developm of therascreen EGFR RGQ PCR Kit for CO-1686 2013-10-21
Mérieux–MC Services: public relations, 201310 service existent for Transgene SA 2013-10-21
Austria (govt)–Biocom: publishing, 201310 supply service with regard to Vienna Life Science Report 2013/14 to LISAvienna by Biocom 2013-10-17
Boehringer–Vector Capital: drug discovery s/w, 201310– supply Certara D360 as drug discovery platform in Ridgefield + Biberach + Vienna 2013-10-17
Suzhou SJ Biomaterials–Scienion: print/spotting technology, 201310– distribution of Scienion products in China by Suzhou SJ Biomaterials Co Ltd 2013-10-17
Sygnature Discovery–Proteros: drug discovery services, 201310– collab strategic alliance to offer integrated services incl X-ray structure analysis 2013-10-17
Photonics Healthcare–Bavaria (govt): investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–High-Tech Gründerfonds: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–SEVERAL: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
CV genes-at-target project–Evotec: genomic drug target discovery, 2013– collab European ScreeningPort is partner in FP7 project 2013-10-15
CV genes-at-target project–Univ Lübeck: genomic drug target discovery, 2013– collab Univ of Lübeck is partner in FP7 project 2013-10-15
Immatics–SEVERAL: investment, 201310 financing round Series D 1st tranche €12m of €34m round Hopp + Strüngmann + Wellington Partners + MIG Funds 2013-10-15
Bayer–BioInvent: antibody library, 201310 license €na extension + broadening to n-CoDeR libraries for development of therapeutic antibodies 2013-10-14
Wilex–MC Services: public relations, 201310 service existent for Wilex AG 2013-10-10
Bayer–RWTH Aachen: bioinformatics, 201310– collab founding of Joint Research Center on Computational Biomedicine by BTS + RWTH 2013-10-09
Bayer–Sysmex: molecular companion diagnostics, 201310– collab master agreem for developm of blood-based CDx for cancer drugs by Sysmex Inostics 2013-10-09
Sartorius–PERSON: investment, 201310 existent family of the late Horst Satorius owns 50.09% bound by last will of Horst Satorius 2013-10-09
Schott–Sony: slides, 201310 collab developm + marketing of glass-plastic hybrid cell imaging slide 2013-10-07
JnJ–CureVac: vaccine technology, 201310– collab + license €na use of RNActive technology for developm of mRNA-based influenza vaccine with Crucell 2013-10-03
Merus–Akampion: public relations, 201310 service existent by Akampion 2013-10-03
Findeisen Laborbedarf–Omnilab (DE): investment, 201310 acquisition of Findeisen Laborbedarf GmbH by Omnilab-Laborzentrum GmbH & Co KG 2013-10-01
Analytik Jena–Endress+Hauser: investment, 201309– mandatory offer for remaining 52.67% of shares for €13.75/share 2013-09-27
next pagenext page 1 2 3 4 ... 62 63 64  next pagenext page



Advertisement

Banner Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Banner AB Sciex Germany 6 Berliner LCMSMS Symposium 600x60px

» top

Advertisements

Banner BIO Deutschland Deutsche Biotechnologietage 2015 Köln 120x240px Banner AB Sciex Germany 6 Berliner LCMSMS Symposium 120x240px Banner EBD Group BIO-Europe Spring 2015 BES Paris France March 120x240px Banner C5 Communications Biotech Patent Litigation 2015 Amsterdam 120x180px Banner Biovision 2014 Lyon France April 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px